CodeMap® Compliance Briefing: September 16, 2020

Editor's Welcome:

Today, we discuss recent Medicare reimbursement and compliance developments, which have occurred over the past few months. Some of these developments may represent significant impacts to clinical laboratories and pathologists, but have not been the focus of the industry due to the ongoing pandemic and economic slowdown. First, we will examine sizable cuts for pathology services that are proposed in the 2021 Medicare Physician Fee Schedule released by CMS last month. We will also examine one notable increase included in that proposed fee schedule. Finally, we will revisit how the CARES Act affects many upcoming provisions of PAMA and resultant market-based fee schedules. As always, we wel....

Sorry, access to this content requires a current subscription.

Click here for publications catalog.

CPT copyright 2024 American Medical Association. All rights reserved.

* The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, nonuse, or interpretation of information contained in this product.